NextPlat Corp. (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions, reported third-quarter 2026 revenue of approximately $10.5 million, compared with $13.8 million in the prior-year period. The decline reflected lower pharmacy reimbursement rates and retail prescription volumes. Despite the revenue drop, gross margin improved to approximately 35% from 19.9%, while net loss attributable to common stockholders narrowed 66% to approximately $700,000, or $0.28 per diluted share, from $2.2 million, or $0.84 per diluted share.
Pharmacy contract revenue increased 300% to approximately $2.4 million, driven by growth in higher-margin 340B services, while e-commerce revenue rose 3% to approximately $3.8 million. The company ended the quarter with approximately $11.2 million in cash and $13.5 million in working capital, with no material unsecured debt. NextPlat continued expanding its healthcare operations through the acquisition of Scott’s Pharmacy near Pensacola, Florida, and the opening of a new Jacksonville location. The company also plans to launch a nationwide medication fulfillment website in the fourth quarter, providing consumers across all 50 states with online access to prescription and over-the-counter healthcare products. Management expects contributions from its expanded pharmacy network and new contracted services to support future growth.
The sharp reduction in net loss and margin expansion are significant for investors, as they indicate improved operational efficiency and a strategic shift toward higher-margin services. The 300% growth in pharmacy contract revenue underscores the potential of the 340B program, which allows eligible healthcare organizations to purchase outpatient drugs at reduced prices. NextPlat’s expansion into new pharmacy locations and the upcoming nationwide fulfillment website could further diversify revenue streams and enhance customer reach. For the healthcare industry, the move toward online prescription fulfillment aligns with broader trends in telemedicine and e-commerce, potentially increasing competition among pharmacy chains and digital health platforms.
To view the full press release, visit https://ibn.fm/8alUs. The latest news and updates relating to NXPL are available in the company’s newsroom at https://ibn.fm/NXPL. The press release was distributed by InvestorWire, a specialized communications platform that is part of the Dynamic Brand Portfolio at IBN. InvestorWire provides access to a vast network of wire solutions, including editorial syndication to 5,000+ outlets and social media distribution to millions of followers. For more information, please see the full terms of use and disclaimers on the InvestorWire website at https://www.InvestorWire.com/Disclaimer.
